John R. Srigley

John R. Srigley

Auto-generated profile, based on publicly available information

John R. Srigley

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2009 in Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JSJohn R. Srigley
John R. Srigley
TMTom McGowan
Tom McGowan
AMAndrea MacLean
Andrea MacLean
MRMarilyn Raby
Marilyn Raby
JRJillian Ross
Jillian Ross
CSCarol Sawka
Carol Sawka
Cancer pathology reports contain information which is critical for patient management and for cancer surveillance, resource planning, and quality purposes. The College of American Pathologists (CAP) has defined scientifically validated content of checklists that form the basis for synoptic cancer pathology reporting. We outline how the CAP standards were implemented in a large Canadian province over a 3‐year period resulting in improvements in rates of synoptic reporting and completeness of cancer pathology reporting. J. Surg. Oncol. 2009;99:517–524.

1 June 2009 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
JSJohn R Srigley
John R Srigley
BDBrett Delahunt
Brett Delahunt
Major consensus conferences held over a decade ago laid the foundations for the current (2004) WHO classification of renal carcinoma. Clear cell, papillary and chromophobe carcinomas account for 85–90% carcinomas seen in routine practice. The remaining 10–15% of carcinomas consist of rare sporadic and hereditary tumors, some of which had been long recognized, but many of which only emerged as distinct entities in the decade leading up to the WHO publication. Collecting-duct carcinoma is a rare, often lethal form of carcinoma. Medullary carcinoma associated with sickle cell trait, has emerged as a distinctive tumor showing some overlapping features with upper tract urothelial carcinoma. Mucinous tubular and spindle-cell carcinoma and tubulocystic carcinoma were earlier considered as patterns of low-grade collecting-duct carcinoma, but are now recognized as separate tumor entities. Carcinomas associated with somatic translocations of TFE3 and TFEB comprise a significant proportion of pediatric renal carcinomas. Oncocytoid renal carcinomas in neuroblastoma survivors was recognized as a unique tumor category in the WHO classification. Renal carcinoma associated with end-stage renal disease is now recognized as having distinct morphological patterns and behavior. In addition there is a group of rare recently described carcinomas, including clear cell papillary carcinoma, oncocytic papillary renal cell carcinoma, follicular renal carcinoma and leiomyomatous renal cell carcinoma. It behooves the surgical pathologist to not only be capable of diagnosing the common forms of renal cancer, but also to be aware of the rare types of renal carcinoma, many of which have emerged in recent years.

1 March 2004 in Laboratory Investigation
Verified
Journal Article
Closed access
JSJohn R Srigley
John R Srigley

1 March 2006 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JSJohn R. Srigley
John R. Srigley
Context. —Patients with prostatic adenocarcinoma commonly undergo radical prostatectomy, and it is often difficult and time consuming to handle the resulting specimens and to report the findings. Pathologic information derived from the radical prostatectomy specimen is used for selecting adjuvant therapy, such as radiotherapy and hormone therapy, and for determining a patient's prognosis. The prostate specimen must be handled in a systematic fashion to derive the appropriate prognostic parameters. Objective. —To review the prognostic factors of relevance in classifying radical prostatectomy specimens, using the College of American Pathologists categorization system, including a detailed survey of the morphologic-based factors but excluding other factors such as DNA ploidy and novel phenotypic and genotypic markers. Conclusions. —Gleason score, pathologic stage, and margin status are considered category 1 prognostic factors, which are of proven prognostic significance and are useful in patient management. Factors such as tumor volume (intraglandular extent) and tumor subtype are considered category 2 prognostic factors, which show significant promise but require validation in multivariate analysis. Lymphovascular space invasion is a promising category 3 prognostic factor that needs additional study. Perineural invasion is an almost ubiquitous finding in radical prostatectomy specimens and is considered a category 3 prognostic factor. After prognostic factors have been analyzed at the histologic level, it is critical to report the findings in a clear and unambiguous fashion. The synoptic style of reporting is ideal for describing complex cancer resection specimens. A synoptic report based on an evidence-based checklist, such as the one developed by the College of American Pathologists, effectively communicates complex cancer-related data, such as radical prostatectomy specimen findings. This information is used not only for individual case management with respect to treatment and prognostication but also for purposes such as education, research, quality monitoring, and system planning.

23 December 2011 in Histopathology
Verified
Journal Article
Closed access
PDF file
JSJohn R Srigley
John R Srigley
BDBrett Delahunt
Brett Delahunt
AEAndrew J Evans
Andrew J Evans

1 July 2006 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JSJohn R. Srigley
John R. Srigley
MAMahul B. Amin
Mahul B. Amin
JEJonathan I. Epstein
Jonathan I. Epstein
DGDavid J. Grignon
David J. Grignon
PHPeter A. Humphrey
Peter A. Humphrey
TWThomas M. Wheeler
Thomas M. Wheeler